A comprehensive Medline search was done with the MeSH terms “irritable bowel syndrome” and “functional bowel disease” from 1997 until February, 2002. Only articles published in English were retrieved. Furthermore, a hand search of abstracts published in Gastroenterology on irritable bowel syndrome over the past 4 years was undertaken, but only those that provided important insights or had high further reading value have been cited.
SeminarIrritable bowel syndrome: a little understood organic bowel disease?
Section snippets
New definitions: confusion and consensus
The term irritable bowel was probably first coined in 1944 by Peters and Bargen.1 Irritable bowel syndrome was deemed a diagnosis of exclusion until Heaton's research group in Bristol reported that six symptoms could discriminate people diagnosed with the disorder (based on an absence of organic disease on follow-up) from those with documented structural bowel disease (panel 1). Presence of two or three symptoms, referred to as the Manning criteria,2 were subsequently applied in many
Epidemiology
Gastrointestinal symptoms are strikingly frequent in the general population: 60–70% of people report one or more troublesome symptoms, suggesting that to be completely asymptomatic could be abnormal.11 Irritable bowel syndrome is clearly one of the most frequent explanations for chronic symptoms, although true prevalence varies—depending on criteria used—from 3% to 22%.6, 11, 12 Prevalence of this disorder is only slightly reduced in elderly people, in whom it is often misdiagnosed.
Health care-seeking behaviour
Not all people with irritable bowel syndrome present for medical care—the proportion who do varies greatly between countries.11, 24, 25 Much of the variation in rates of health care-seeking behaviour is probably attributable to characteristics associated with a country or region's health-care system (including access and who pays).
Social learning in early childhood could contribute to frequent seeking of health care for symptoms of irritable bowel syndrome. Levy26 reported that children whose
Mechanisms
The symptoms of irritable bowel syndrome are pain, bloating, and an altered bowel habit. Putative mechanisms include visceral hypersensitivity, altered motility, abnormal transit of stool and gas, and stress, more than one of which could contribute to symptoms, which after cognitive appraisal lead to patient's behaviour, including consultation (figure 1). Genetic factors affecting pain-signalling and disturbances in central processing of afferents are postulated to predispose to irritable bowel
Diagnosis
There is presently no established biological marker for irritable bowel syndrome. For example, colonic balloon distension testing is invasive and is not sensitive and specific enough to justify its clinical use. One of the main reasons that family doctors refer patients with symptoms of irritable bowel syndrome to hospital is the possibility that they might have another disease. Thus, it is not surprising that incidence of organic disease is higher in patients referred to a specialist than in
Education and support
Authors of several consensus reports107, 114, 115 have made management recommendations and reached similar conclusions (panel 3). After a positive diagnosis based on symptoms, education and support of patients is essential to deal with what is often a lifelong disorder. Establishment of a positive doctor-patient relationship is important to provide good clinical care, especially in view of qualitative evidence that patients with irritable bowel syndrome generally perceive their doctor to have
New and alternative treatments
Several compounds are under development or in early testing for irritable bowel treatment (panel 5). It remains to be seen if pharmacogenetics or other means of subgrouping the disorder will lead to drug advances.
Psychological treatments are thought to be of value in irritable bowel syndrome. Cognitive behavioural therapy, relaxation, and psychotherapy have been reported to be superior to standard care in most patients,130, 131, 132, 133 but methodological concerns have been raised with most of
Conclusions
Irritable bowel syndrome is a major cause of morbidity and deserves serious attention. Although stress can stimulate the colon in this disorder and in health, this factor cannot be the only cause of symptoms. Evidence is growing that irritable bowel syndrome can no longer be purely regarded as a functional disorder—which is a loose term frequently used to describe anything that we cannot adequately explain, or probable psychiatric disease. We prefer to judge the disorder to be a discrete
Search strategy and selection criteria
References (140)
- et al.
Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?
Am J Gastroenterol
(2000) - et al.
Gender-related differences in IBS symptoms
Am J Gastroenterol
(2001) - et al.
Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome
Am J Gastroenterol
(1999) - et al.
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome
Am J Gastroenterol
(2000) - et al.
The impact of irritable bowel syndrome on health-related quality of life
Gastroenterology
(2000) - et al.
The burden of selected digestive diseases in the United States
Gastroenterology
(2002) - et al.
Functional somatic syndromes: one or many?
Lancet
(1999) - et al.
Antibiotics increase functional abdominal complaints
Am J Gastroenterol
(2002) - et al.
Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychological factors
Am J Gastroenterol
(2001) - et al.
Intergenerational transmission of gastrointestinal illness behavior
Am J Gastroenterol
(2000)
A multivariate study of patients and nonpatients with irritable bowel syndrome
Gastroenterology
Bowel patterns among subjects not seeking health care: use of a questionnaire to identify a population with bowel dysfunction
Gastroenterology
Altered rectal perception is a biological marker of patients with irritable bowel syndrome
Gastroenterology
Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome
Gastroenterology
Site of pain from the irritable bowel
Lancet
Regional cerebral activity in normal and pathological perception of visceral pain
Gastroenterology
Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention
Gastroenterology
Gastric distention correlates with activation of multiple cortical and subcortical regions
Gastroenterology
Central nervous pathways mediating angina pectoris
Lancet
Anticipatory coping of pain expressed in the human anterior cingulate cortex: a positron emission tomography study
Neurosci Lett
Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea
Am J Gastroenterol
Abdominal wall muscle activity in irritable bowel syndrome with bloating
Am J Gastroenterol
Abnormal colonic fermentation in irritable bowel syndrome
Lancet
Intestinal gas dynamics and tolerance in humans
Gastroenterology
Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome
Gastroenterology
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
Lancet
A role for 5-hydroxytryptamine (5-HT) in the post-prandial exacerbation of symptoms in female patients with diarrhoea predominant irritable bowel syndrome (IBS)
Gastroenterology
Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome
Am J Gastroenterol
The irritable bowel syndrome and psychiatric disorders in the community: is there a link?
Am J Gastroenterol
Altered pain perception and psychosocial features among women with gastrointestinal disorders and a history of abuse: a preliminary model
Am J Med
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology
Gastroenterology
Evidence of a genetic contribution to functional bowel disorder
Am J Gastroenterol
The relationship between irritable bowel syndrome and psychiatric illness: a family study
Psychosomatics
The irritable bowel syndrome
Gastroenterology
Towards positive diagnosis of the irritable bowel
BMJ
Rome II: the functional gastrointestinal disorders
Gender differences in irritable bowel symptoms
Eur J Gastroenterol Hepatol
Irritable bowel syndrome: which definitions are consistent
J Intern Med
The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers
Gut
The epidemiology of hysterectomy and irritable bowel syndrome in a UK population
Br J Surg
US householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact
Dig Dis Sci
Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome
Ann Intern Med
Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population
Gut
Irritable bowel syndrome and upper dyspepsia among the elderly: a study of symptom clusters in a random 70 year old population
Eur J Epidemiol
The clinical course and prognostic determinants of the irritable bowel syndrome: a literature review
Scand J Gastroenterol
Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders
Am J Epidemiol
Irritable bowel syndrome symptom patterns: frequency, duration, and severity
Dig Dis Sci
The irritable bowel syndrome: long-term prognosis and the physician-patient interaction
Ann Intern Med
A population study on irritable bowel syndrome and mental health
Scand J Gastroenterol
Cited by (240)
Thalamic abnormalities in older adults with remitted early-onset depression using structural magnetic resonance imaging
2022, Journal of Affective DisordersCitation Excerpt :Five participants taking antidepressants did not have a lifetime history of MDD. However, older adults are often prescribed antidepressants in the absence of a MDD in order to treat a number of conditions including sleep disturbances (Reynolds and Adams, 2019), anxiety (Flint, 2005), incontinence and irritable bowel syndrome (Talley and Spiller, 2002), as well as pain conditions (e.g., neuropathic pain, migraine, fibromyalgia) (Tamblyn et al., 2020). Neuropsychological.
Fatigue in irritable bowel syndrome is associated with plasma levels of TNF-α and mesocorticolimbic connectivity
2021, Brain, Behavior, and ImmunityComparison of comorbid depression between irritable bowel syndrome and inflammatory bowel disease: A meta-analysis of comparative studies
2018, Journal of Affective DisordersAbdominal Pain
2018, Nelson Pediatric Symptom-Based Diagnosis